Surgery and radiotherapy in the treatment of cutaneous melanoma
Alessandro Testori(European Organisation for Research and Treatment of Cancer), Alexander M.M. Eggermont(University Medical Center Utrecht), Piotr Rutkowski(The Maria Sklodowska-Curie National Research Institute of Oncology), Jerry Marsden, A. Hauschild(Christian-Albrechts-Universität zu Kiel), Lars Bastholt(Odense University Hospital), Vanna Chiarion‐Sileni(Centre Hospitalier Universitaire Brugmann)
Cited by 140
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k